Dupilumab (blinded)

( DrugBank: Dupilumab / KEGG DRUG: Dupilumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
98	好酸球性消化管疾患	1

98. 好酸球性消化管疾患

臨床試験数 : 172 / 薬物数 : 149 - (DrugBank : 39) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 135

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03678545 (ClinicalTrials.gov)	May 15, 2021	6/8/2018	Dupilumab in Eosinophilic Gastritis	A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab( ...	Eosinophilic Gastritis;Eosinophilic Gastroenteritis	Drug: Dupilumab (blinded);Drug: Placebo (blinded);Drug: Dupilumab (open-label)	Children's Hospital Medical Center, Cincinnati	Regeneron Pharmaceuticals;National Institutes of Health (NIH)	Recruiting	12 Years	70 Years	All	40	Phase 2	United States

First Previous1Next Last